By : Andre Anderson
=”b-item__description”>People with multiple sclerosis may have a medical marijuana gum available for treatment of symptoms by 2017 if upcoming study results are positive. Made by AXIM Biotechnology Inc., gum called MedChew Rx.Medical marijuana doctors expect that medical marijuana gum can treat pain and spasticity. Thus the company expects that Food and Drug Administration and the European Medicines Agency will approve this product for their use.
The ingredients of MedChew Rx is 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC). It is suggested that it will be available by prescription.
Cannabidiol is one of more than 100 cannabinoid chemicals found in marijuana seeds. It has been shown to possess multiple health benefits, which includes the ability to treat seizures and other neurological conditions. THC, another type of cannabinoid, has psychoactive properties as well as medicinal abilities.
According to Dr. George E. Anastassoy, MD, DDS, MBA, chief executive officer of AXIM Biotechnology, the marijuana gum is unique because of its “precise, controlled release mechanism to the oral mucosal capillary circulation”. His words mean that it bypasses the liver. Obtaining the marijuana components via chewing also is safer, associated with fewer side effects, and more socially acceptable than traditional methods, such as smoking or oral consumption, according to Professor John Zajicek, an expert on medical cannabis and the individual responsible for conducting AXIM’s clinical trials on pain and spasticity in multiple sclerosis.
=”entry-content”>=”b-item__description”>The gum also provides “neuroprotective and neurostimulatory benefits” derived from chewing, an activity which itself has a therapeutic impact. In fact, research has shown that chewing (mastication) promotes generation of neurons (neurogenesis), stimulates the cardiovascular system, and enhances oral health, as well as helps with stress reduction and loss of cognition associated with aging.